Nutex Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,052	172	121	1,237	-	-
Market Cap Growth	492.02%	42.70%	-90.24%	-	-	-
Enterprise Value	1,245	448	437	1,484	-	-
Last Close Price	148.79	31.69	27.00	285.00	-	-
PE Ratio	8.28	3.31	-	-	-	-
PS Ratio	0.90	0.36	0.49	5.64	-	-
PB Ratio	3.24	0.91	1.53	10.28	-	-
P/TBV Ratio	3.74	1.67	5.06	21.46	-	-
P/FCF Ratio	6.04	8.26	-	34.39	-	-
P/OCF Ratio	5.92	7.44	96.10	24.45	-	-
EV/Sales Ratio	1.27	0.93	1.76	6.77	-	-
EV/EBITDA Ratio	3.28	2.86	26.79	173.52	-	-
EV/EBIT Ratio	3.47	3.25	-	-	-	-
EV/FCF Ratio	7.14	21.49	-	41.25	-	-
Debt / Equity Ratio	0.82	1.81	3.49	2.22	0.93	1.02
Debt / EBITDA Ratio	0.94	2.14	14.55	23.19	0.97	0.94
Debt / FCF Ratio	2.06	16.32	-	7.43	1.31	5.89
Asset Turnover	1.40	0.91	0.60	0.53	0.94	1.12
Inventory Turnover	155.36	84.84	56.41	60.10	63.70	79.65
Quick Ratio	3.09	1.79	1.45	1.69	4.00	4.25
Current Ratio	3.20	1.90	1.56	1.79	4.09	4.31
Return on Equity (ROE)	101.68%	70.85%	-43.55%	-277.48%	99.44%	146.88%
Return on Assets (ROA)	31.98%	16.35%	-0.19%	-0.69%	30.90%	39.25%
Return on Invested Capital (ROIC)	47.46%	28.97%	-0.38%	-1.33%	57.04%	70.38%
Return on Capital Employed (ROCE)	46.10%	27.50%	-0.40%	-1.20%	48.70%	55.30%
Earnings Yield	11.46%	30.24%	-37.92%	-34.34%	-	-
FCF Yield	16.56%	12.10%	-6.83%	2.91%	-	-
Payout Ratio	-	-	-	-	84.24%	43.06%
Buyback Yield / Dilution	-40.46%	-24.57%	-4.15%	-7.10%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q